These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 11555113

  • 1. Rapid response of severe refractory metastatic Crohn's disease to infliximab.
    Miller AM, Elliott PR, Fink R, Connell W.
    J Gastroenterol Hepatol; 2001 Aug; 16(8):940-2. PubMed ID: 11555113
    [Abstract] [Full Text] [Related]

  • 2. Infliximab for the treatment of orofacial Crohn's disease.
    Mahadevan U, Sandborn WJ.
    Inflamm Bowel Dis; 2001 Feb; 7(1):38-42. PubMed ID: 11233659
    [Abstract] [Full Text] [Related]

  • 3. Response of cutaneous Crohn's disease to infliximab and methotrexate.
    Konrad A, Seibold F.
    Dig Liver Dis; 2003 May; 35(5):351-6. PubMed ID: 12846408
    [Abstract] [Full Text] [Related]

  • 4. Metastatic Crohn's disease despite infliximab therapy.
    Campos S, Coutinho I, Cardoso JC, Portela F.
    An Bras Dermatol; 2017 May; 92(5 Suppl 1):104-106. PubMed ID: 29267462
    [Abstract] [Full Text] [Related]

  • 5. Treatment-resistant lingual Crohn's disease disappears after infliximab.
    Brunner B, Hirschi C, Weimann R, Seibold F.
    Scand J Gastroenterol; 2005 Oct; 40(10):1255-9. PubMed ID: 16265783
    [Abstract] [Full Text] [Related]

  • 6. Infliximab: an updated review of its use in Crohn's disease and rheumatoid arthritis.
    Keating GM, Perry CM.
    BioDrugs; 2002 Oct; 16(2):111-48. PubMed ID: 11985485
    [Abstract] [Full Text] [Related]

  • 7. Severe polyneuropathy complicating active Crohn's disease: rapid response to Infliximab.
    Rodinò S, Saccà N, D'Amico T, Fragomeni A, Giglio A.
    Gut; 2003 Jul; 52(7):1070. PubMed ID: 12801971
    [No Abstract] [Full Text] [Related]

  • 8. Infliximab therapy for Crohn's disease in the presence of chronic hepatitis C infection.
    Campbell S, Ghosh S.
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):191-2. PubMed ID: 11246620
    [Abstract] [Full Text] [Related]

  • 9. [Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication].
    Lee KM, Kim JS, Shin DH, Cheong JY, Yoo BM, Kim JK, Lee KJ, Hahm KB, Kim JH, Cho SW.
    Korean J Gastroenterol; 2004 Nov; 44(5):259-66. PubMed ID: 15564805
    [Abstract] [Full Text] [Related]

  • 10. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease.
    Borrelli O, Bascietto C, Viola F, Bueno de Mesquita M, Barbato M, Mancini V, Bosco S, Cucchiara S.
    Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204
    [Abstract] [Full Text] [Related]

  • 11. [Infliximab therapy in children and adolescents with refractory Crohn's disease in the Netherlands; experience with 23 patients].
    de Ridder L, Escher JC, Taminiau JA.
    Ned Tijdschr Geneeskd; 2002 Oct 05; 146(40):1879-83. PubMed ID: 12395595
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Infliximab for the treatment of metastatic hepatic and pulmonary Crohn's disease.
    Gill KR, Mahadevan U.
    Inflamm Bowel Dis; 2005 Feb 05; 11(2):210-2. PubMed ID: 15677920
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Infliximab in the management of the extra-intestinal manifestations of Crohn's disease.
    Lawrance IC.
    J Gastroenterol Hepatol; 2004 Nov 05; 19(11):1332-3. PubMed ID: 15482549
    [No Abstract] [Full Text] [Related]

  • 17. [Anti-TNF antibodies in the treatment of inflammatory intestinal stenoses in Crohn's disease].
    Holtmann M, Wanitschke R, Helisch A, Bartenstein P, Galle PR, Neurath M.
    Z Gastroenterol; 2003 Jan 05; 41(1):11-7. PubMed ID: 12541166
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec 05; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.